Australia's largest stock trading and investment forum Australia's #1 stock forum

IHL

0.00%

4.1¢ incannex healthcare limited

General discussion, page-2262

First 2262 Last

Share
Profile

Follow
Jam_Man07

200 Posts.

83

14/10/20

09:25

Post #: 48074621
Share

Originally posted by andres: ↑

A few observations on psychedelics. Have done some extensive research in this sector looking at listed and unlisted players, institutes, universities and industry bodies as well as the evolution in this area of medicine.

1. There are no ASX competitors in the space.
2. Very little overseas re companies playing in the sector - and a lot of these are "aspirational".
3. Very very few are active in clinic trials and mostly claims are rhetoric.
4. Compass Holdings is perhaps the only real major player and they recently listed and now have a $1 B market cap.
5. Psychedelics, for those who know a bit about its history and evolution, has had a strong history of research and efficacy and it is now resurging. Treatments for PTSD, Depression and Palliative care have shown tremendous results far exceeding the Prozacs of the world and pure psychiatric approaches.
6. There are very few globally recognised experts in the field - we have one with Paul Liknaitzky. (worth researching Paul's profile)
7. The sector has a strong base in legitimacy - worth looking up Johns Hopkins and Usona Institute.

It should also be noted that the companies involved with clinical trials are under close scrutiny from partnering hospitals; a testament to the quality of medical talent IHL has been able to attract and the high standards it adopts.

IMO, IHL is at the forefront of this industry here in Australia and potentially in the top handful of companies at a global level. Very excited to see this unfold...has to be one of the most exciting companies developing unique CBD compound medicinal solutions and now a first mover of significance in psychedelics.

Expand

Very exciting times Andres! I note Compass pathways was up over 10% last night now with a market cap of over $US 1.35b. As I've said this makes IHL being the only psychedelic Asx play very cheap.

If IHL are serious about this space and have a hot program up their sleeve with Dr Paul L, I can easily see 20-30c in the near term.

Hopefully Christmas will come early for us shareholders, you just have to back this management team, they are super switched on and always ahead of the curve.

glta

IHL Price at posting: 9.3¢ Sentiment: Buy Disclosure: Held
15 Upvote

1 Great analysis

Reply

Top Stories

CTT

Cettire shares jump on FY24 revenue growth up 80% vs pcp – but stock still badly bruised

VMM

Virdis Mining flags breakthrough with 76% neodymium and praseodymium recoveries

ATH

Trial for Alterity's neurodegenerative drug ATH434 shows reduced disability

NWC

New World Resources inks complete PFS for Antler Copper Project in Arizona, USA

AX8

Accelerate finds 1.28% lithium at Prinsep in WA, including 150m 'halo' zone